In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by Biotechna SA under agreement No. 2022/ABM/06/ 00005-00 for co-financing of a commercial project as part of the Competition for the development of targeted or personalised medicine based on medicinal products based on nucleic acids and small molecule compounds, the Ordering Party is conducting market research on the costs of purchasing and delivering cartridges for the NanoAssemblr™ Ignite and Ignite+ device
In order to submit an offer, please read the detailed content of the offer included in market survey No. 114/20925 and send the completed offer form and product range and price form.
Request for quotation 114/2025 (PDF, 252 KB)